©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1584-1597
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1584
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1584
Table 3 Patient outcomes following Sengstaken-Blakemore Tube insertion
| Variable | Value (n = 80) |
| Length of stay, d | |
| Total hospital LOS | 11.0 (7.0, 19.5) |
| ICU LOS | 4.90 (2.3, 9.1) |
| Duration of mechanical ventilation, h | 89.5 (39.3, 153.8) |
| Blood product transfusion | |
| Packed red cells, units | 6 (4, 10) |
| Platelets, units | 1 (0, 3) |
| Fresh frozen plasma, units | 2 (1, 6) |
| Achieved primary haemostasis | 73 (91.3) |
| Re-bleeding | 25 (34.2) |
| Complications of SBT | 19 (34.5) |
| Mucosal ulceration and tears (without perforation) | 17 (89.5) |
| Aspiration pneumonia | 4 (21.0) |
| Perforation | 1 (5.3) |
| TIPS | |
| Underwent TIPS | 17 (21.3) |
| Time to TIPS from SBT, d | 2.95 (1.4, 4.1) |
| Survival | |
| Survived hospital admission | 41 (51.2) |
| Alive at 6 wk | 41 (51.2) |
| Alive at 26 wk | 39 (48.8) |
| Alive at 52 wk | 37 (46.3) |
- Citation: Keung CY, Morgan A, Le ST, Robertson M, Urquhart P, Swan MP. Survival outcomes and predictors of mortality, re-bleeding and complications for acute severe variceal bleeding requiring balloon tamponade. World J Hepatol 2022; 14(8): 1584-1597
- URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1584.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i8.1584